Generali Asset Management Spa Sgr Regeneron Pharmaceuticals, Inc. Transaction History
Generali Asset Management Spa Sgr
- $4.39 Trillion
- Q2 2025
A detailed history of Generali Asset Management Spa Sgr transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Generali Asset Management Spa Sgr holds 12,684 shares of REGN stock, worth $7.14 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
12,684
Previous 11,034
14.95%
Holding current value
$7.14 Million
Previous $7 Billion
4.84%
% of portfolio
0.15%
Previous 0.17%
Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,417Shares Held
85MCall Options Held
1.39MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.3 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.76 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.19 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.7 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.25 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $60.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...